Welcome to ECTRIMS
This page is your gateway to the Roche presence at ECTRIMS 2024.
Explore it to learn how we are changing MS together!
-
MS Symposium
MatterS of our time: Unlocking the full potential of aCD20 therapy
-
Brain Exchange
NMOSD/MOGAD – Critical comparisons for clinicians
-
Brain Exchange
How could NfL transform the patient journey?
-
Brain Exchange
Role of neurologists in brain health
-
Brain Exchange
Equitable access and patient-centred treatment in MS
-
Oral Communication
Effect of ocrelizumab on biomarkers (OBOE)
-
Oral Communication
Dose selection (OPERETTA)
-
Oral Communication
Ocrelizumab and family planning decisions (SOPRANINO)
Explore the full program of Roche activities @ECTRIMS 2024.
Connect with leading experts, deepen your understanding and see how we are changing MS together.
Explore the scientific programmes
You are Leaving Medically
By following this link, you are leaving Roche Website and entering a site that is not owned or controlled by Roche. Roche does not take any responsibility for acces to or use of this website, nor for any content therein.
You are Leaving the Global Medically Site
By following this link, you are being redirected to another Roche page.